Abbott LaboratoriesAbbott LaboratoriesAbbott Laboratories

Abbott Laboratories

No trades
See on Supercharts
Market capitalization
‪188.94 B‬USD
‪5.70 B‬USD
‪40.11 B‬USD
‪1.72 B‬
Beta (1Y)
0.57

About Abbott Laboratories

CEO
Robert B. Ford
Website
Headquarters
Abbott Park
Employees (FY)
‪114 K‬
Founded
1888
ISIN
US0028241000
FIGI
BBG000B9ZXB4
Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ABT is 109.21 USD — it has increased by 0.29% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Abbott Laboratories stocks are traded under the ticker ABT.
Abbott Laboratories is going to release the next earnings report on Apr 17, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Abbott Laboratories has a max estimate of 141.00 USD and a min estimate of 107.00 USD.
ABT earnings for the last quarter are 1.14 USD whereas the estimation was 1.10 USD which accounts for 3.57% surprise. Estimated earnings for the next quarter are 1.19 USD. See more details about Abbott Laboratories earnings.
Abbott Laboratories revenue for the last quarter amounts to ‪10.14 B‬ USD despite the estimated figure of ‪9.84 B‬ USD. In the next quarter revenue is expected to reach ‪10.19 B‬ USD.
Yes, you can track Abbott Laboratories financials in yearly and quarterly reports right on TradingView.
Like other stocks, ABT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Abbott Laboratories stock right from TradingView charts — choose your broker and connect to your account.
ABT reached its all-time high on Dec 27, 2021 with the price of 142.60 USD, and its all-time low was 0.11 USD and was reached on Oct 4, 1974.
See other stocks reaching their highest and lowest prices.
As of Apr 17, 2024, the company has ‪114.00 K‬ employees. See our rating of the largest employees — is Abbott Laboratories on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Abbott Laboratories EBITDA is ‪9.70 B‬ USD, and current EBITDA margin is 24.13%. See more stats in Abbott Laboratories financial statements.